that is correct.It is not just ROP but all conditions related to prematurity.Insmed has given up all rights to any revenues that Shire may gain from this area
Nice thread.The meeting will not be public and will take a considerable time.
The President is taking the best possible outcome.Government agencies have their own clock.
late 2015 if they have the data.2018 if they do not.
This is all the work of one or maybe 2 people.I bought 3000 shares this morning. These Yahoo boards have really gone downhill since they changed to the tablet format. expect news in 6-8 weeks
why do I keep hearing this and the stock just keeps going up? To filter these cheerleaders takes time.
spelling aside,this is a correct statement..No one knows how Arikace will be used in therapy.===yet.===== or how effective so by orphaning Arikace gives Insmed advantage.This is a board for stock holders who think you can rank out reality.I wish you all a Happy Easter and best success for Arikace.
yous tak funnie,but seriously]]]]] any one that has any knowledge of this company and their pipeline knows this board is over run by a few kids ]]]] Insmed will be taken over ] if arikace is approved]]iplex has no part of that equation.
guess 8 thumbs down from stock holders makes it not true.iplex is gone for this company and I say the drug is dead for anyone else because of the side effects I mentioned.
zake Your statement that iplex has no side effects is ignorance.hypoglycemia tonsil inflammation are just two.You have no qualifications on this drug to be making such a statement;; that is so very obvious.
Its blsheet Insmed has a long approval process and a limited market as of Now.IF parameters of safety and application are acheived this biotech company can move forward.These highfalutin tales of riches are nonsense.
by accident, I googled my way into this food fight...
since I have a background in manufaturing ( major biochem) ,. I know that mfg and the Merck conversion do not compute ... until a better mfg method, iplex is worthless